Literature DB >> 25764218

mTOR signaling and transcriptional regulation in T lymphocytes.

Hu Zeng1, Hongbo Chi.   

Abstract

The mechanistic target of rapamycin (mTOR) signaling integrates diverse environmental cues, including growth factors, nutrients and immunological signals. Activation of mTOR signaling stimulates protein synthesis and anabolic metabolism and coordinates cell growth, proliferation and fate decisions. In recent years, mTOR signaling has been linked to the entire spectrum of T cell biology, ranging from T cell development and activation to lineage specification and memory formation. Mechanistically, mTOR activation profoundly affects the expression and activity of many immunologically relevant transcription factors to propagate immune signaling and mediate effector functions. These transcription factors orchestrate cell metabolism (MYC, SREBPs and HIF1), lineage differentiation (T-bet, GATA3, RORγt, FOXP3 and Eomesodermin) and immune activation and functions (NF-κB, FOXOs, IRF4, STATs and GFI-1). This review discusses how mTOR signaling, through impinging upon transcriptional factors, regulates T cell development, activation, and effector and memory differentiation.

Entities:  

Keywords:  Eukaryotic transcription; transcription factors and co-activators

Mesh:

Substances:

Year:  2014        PMID: 25764218      PMCID: PMC4214230          DOI: 10.4161/trns.28263

Source DB:  PubMed          Journal:  Transcription        ISSN: 2154-1272


  64 in total

1.  Repression of the transcription factor Bach2 contributes to predisposition of IgG1 memory B cells toward plasma cell differentiation.

Authors:  Kohei Kometani; Rinako Nakagawa; Ryo Shinnakasu; Tomohiro Kaji; Andrei Rybouchkin; Saya Moriyama; Koji Furukawa; Haruhiko Koseki; Toshitada Takemori; Tomohiro Kurosaki
Journal:  Immunity       Date:  2013-07-11       Impact factor: 31.745

2.  AKT promotes rRNA synthesis and cooperates with c-MYC to stimulate ribosome biogenesis in cancer.

Authors:  Joanna C Chan; Katherine M Hannan; Kim Riddell; Pui Yee Ng; Abigail Peck; Rachel S Lee; Sandy Hung; Megan V Astle; Megan Bywater; Meaghan Wall; Gretchen Poortinga; Katarzyna Jastrzebski; Karen E Sheppard; Brian A Hemmings; Michael N Hall; Ricky W Johnstone; Grant A McArthur; Ross D Hannan; Richard B Pearson
Journal:  Sci Signal       Date:  2011-08-30       Impact factor: 8.192

3.  The transcription factor Myc controls metabolic reprogramming upon T lymphocyte activation.

Authors:  Ruoning Wang; Christopher P Dillon; Lewis Zhichang Shi; Sandra Milasta; Robert Carter; David Finkelstein; Laura L McCormick; Patrick Fitzgerald; Hongbo Chi; Joshua Munger; Douglas R Green
Journal:  Immunity       Date:  2011-12-23       Impact factor: 31.745

4.  Serine phosphorylation and maximal activation of STAT3 during CNTF signaling is mediated by the rapamycin target mTOR.

Authors:  K Yokogami; S Wakisaka; J Avruch; S A Reeves
Journal:  Curr Biol       Date:  2000-01-13       Impact factor: 10.834

5.  Translational control of c-MYC by rapamycin promotes terminal myeloid differentiation.

Authors:  Meaghan Wall; Gretchen Poortinga; Katherine M Hannan; Richard B Pearson; Ross D Hannan; Grant A McArthur
Journal:  Blood       Date:  2008-07-11       Impact factor: 22.113

6.  Gfi1 negatively regulates T(h)17 differentiation by inhibiting RORgammat activity.

Authors:  Kenji Ichiyama; Masayuki Hashimoto; Takashi Sekiya; Ryusuke Nakagawa; Yu Wakabayashi; Yuki Sugiyama; Kyoko Komai; Ingrid Saba; Tarik Möröy; Akihiko Yoshimura
Journal:  Int Immunol       Date:  2009-06-07       Impact factor: 4.823

7.  The tumor suppressor Tsc1 enforces quiescence of naive T cells to promote immune homeostasis and function.

Authors:  Kai Yang; Geoffrey Neale; Douglas R Green; Weifeng He; Hongbo Chi
Journal:  Nat Immunol       Date:  2011-07-17       Impact factor: 25.606

8.  PDK1 regulation of mTOR and hypoxia-inducible factor 1 integrate metabolism and migration of CD8+ T cells.

Authors:  David K Finlay; Ella Rosenzweig; Linda V Sinclair; Carmen Feijoo-Carnero; Jens L Hukelmann; Julia Rolf; Andrey A Panteleyev; Klaus Okkenhaug; Doreen A Cantrell
Journal:  J Exp Med       Date:  2012-11-26       Impact factor: 14.307

9.  Down-regulation of Gfi-1 expression by TGF-beta is important for differentiation of Th17 and CD103+ inducible regulatory T cells.

Authors:  Jinfang Zhu; Todd S Davidson; Gang Wei; Dragana Jankovic; Kairong Cui; Dustin E Schones; Liying Guo; Keji Zhao; Ethan M Shevach; William E Paul
Journal:  J Exp Med       Date:  2009-02-02       Impact factor: 14.307

10.  SREBP activity is regulated by mTORC1 and contributes to Akt-dependent cell growth.

Authors:  Thomas Porstmann; Claudio R Santos; Beatrice Griffiths; Megan Cully; Mary Wu; Sally Leevers; John R Griffiths; Yuen-Li Chung; Almut Schulze
Journal:  Cell Metab       Date:  2008-09       Impact factor: 27.287

View more
  19 in total

Review 1.  Cell type-specific mechanistic target of rapamycin-dependent distortion of autophagy pathways in lupus nephritis.

Authors:  Tiffany Caza; Chathura Wijewardena; Laith Al-Rabadi; Andras Perl
Journal:  Transl Res       Date:  2022-03-12       Impact factor: 10.171

2.  Reactive Oxygen Species-Mediated c-Jun NH2-Terminal Kinase Activation Contributes to Hepatitis B Virus X Protein-Induced Autophagy via Regulation of the Beclin-1/Bcl-2 Interaction.

Authors:  Linmao Zhong; Wangqin Shu; Wangbin Dai; Bo Gao; Sidong Xiong
Journal:  J Virol       Date:  2017-07-12       Impact factor: 5.103

Review 3.  Differential T-cell receptor signals for T helper cell programming.

Authors:  Penelope A Morel
Journal:  Immunology       Date:  2018-05-25       Impact factor: 7.397

Review 4.  Feeding an army: The metabolism of T cells in activation, anergy, and exhaustion.

Authors:  Greg M Delgoffe; Jonathan D Powell
Journal:  Mol Immunol       Date:  2015-12       Impact factor: 4.407

5.  Natural killer group 2D and CD28 receptors differentially activate mammalian/mechanistic target of rapamycin to alter murine effector CD8+ T-cell differentiation.

Authors:  Bryan McQueen; Kelsey Trace; Emily Whitman; Taylor Bedsworth; Amorette Barber
Journal:  Immunology       Date:  2016-01-17       Impact factor: 7.397

6.  The E3 ubiquitin ligase Peli1 regulates the metabolic actions of mTORC1 to suppress antitumor T cell responses.

Authors:  Chun-Jung Ko; Lingyun Zhang; Zuliang Jie; Lele Zhu; Xiaofei Zhou; Xiaoping Xie; Tianxiao Gao; Jin-Young Yang; Xuhong Cheng; Shao-Cong Sun
Journal:  EMBO J       Date:  2020-11-20       Impact factor: 11.598

Review 7.  Adjunct Strategies for Tuberculosis Vaccines: Modulating Key Immune Cell Regulatory Mechanisms to Potentiate Vaccination.

Authors:  Lakshmi Jayashankar; Richard Hafner
Journal:  Front Immunol       Date:  2016-12-16       Impact factor: 7.561

Review 8.  Targeting T Cell Metabolism for Improvement of Cancer Immunotherapy.

Authors:  Thibault Le Bourgeois; Laura Strauss; Halil-Ibrahim Aksoylar; Saeed Daneshmandi; Pankaj Seth; Nikolaos Patsoukis; Vassiliki A Boussiotis
Journal:  Front Oncol       Date:  2018-08-03       Impact factor: 6.244

9.  mTOR intersects antibody-inducing signals from TACI in marginal zone B cells.

Authors:  Jordi Sintes; Maurizio Gentile; Shuling Zhang; Yolanda Garcia-Carmona; Giuliana Magri; Linda Cassis; Daniel Segura-Garzón; Alessandra Ciociola; Emilie K Grasset; Sabrina Bascones; Laura Comerma; Marc Pybus; David Lligé; Irene Puga; Cindy Gutzeit; Bing He; Wendy DuBois; Marta Crespo; Julio Pascual; Anna Mensa; Juan Ignacio Aróstegui; Manel Juan; Jordi Yagüe; Sergi Serrano; Josep Lloreta; Eric Meffre; Michael Hahne; Charlotte Cunningham-Rundles; Beverly A Mock; Andrea Cerutti
Journal:  Nat Commun       Date:  2017-11-13       Impact factor: 14.919

10.  T Cell Metabolism in Cancer Immunotherapy.

Authors:  Halil-Ibrahim Aksoylar; Natalia M Tijaro-Ovalle; Vassiliki A Boussiotis; Nikolaos Patsoukis
Journal:  Immunometabolism       Date:  2020-06-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.